These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
688 related articles for article (PubMed ID: 25689902)
1. Lipidomics applications for disease biomarker discovery in mammal models. Zhao YY; Cheng XL; Lin RC; Wei F Biomark Med; 2015; 9(2):153-68. PubMed ID: 25689902 [TBL] [Abstract][Full Text] [Related]
2. Lipidomics applications for discovering biomarkers of diseases in clinical chemistry. Zhao YY; Cheng XL; Lin RC Int Rev Cell Mol Biol; 2014; 313():1-26. PubMed ID: 25376488 [TBL] [Abstract][Full Text] [Related]
3. Recent advances in lipidomics: Analytical and clinical perspectives. Sethi S; Brietzke E Prostaglandins Other Lipid Mediat; 2017 Jan; 128-129():8-16. PubMed ID: 28039059 [TBL] [Abstract][Full Text] [Related]
4. Lipidomics, Biomarkers, and Schizophrenia: A Current Perspective. Sethi S; Hayashi MA; Barbosa BS; Pontes JG; Tasic L; Brietzke E Adv Exp Med Biol; 2017; 965():265-290. PubMed ID: 28132184 [TBL] [Abstract][Full Text] [Related]
5. Analytical strategies in lipidomics and applications in disease biomarker discovery. Hu C; van der Heijden R; Wang M; van der Greef J; Hankemeier T; Xu G J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Sep; 877(26):2836-46. PubMed ID: 19233743 [TBL] [Abstract][Full Text] [Related]
6. Lipidomics: Novel insight into the biochemical mechanism of lipid metabolism and dysregulation-associated disease. Zhao YY; Miao H; Cheng XL; Wei F Chem Biol Interact; 2015 Oct; 240():220-38. PubMed ID: 26358168 [TBL] [Abstract][Full Text] [Related]
7. Analytical approaches for lipidomics and its potential applications in neuropsychiatric disorders. Sethi S; Hayashi MA; Sussulini A; Tasic L; Brietzke E World J Biol Psychiatry; 2017 Oct; 18(7):506-520. PubMed ID: 26555297 [TBL] [Abstract][Full Text] [Related]
8. Ultra-performance liquid chromatography-mass spectrometry as a sensitive and powerful technology in lipidomic applications. Zhao YY; Wu SP; Liu S; Zhang Y; Lin RC Chem Biol Interact; 2014 Sep; 220():181-92. PubMed ID: 25014415 [TBL] [Abstract][Full Text] [Related]
9. Optimizing the lipidomics workflow for clinical studies--practical considerations. Hyötyläinen T; Orešič M Anal Bioanal Chem; 2015 Jul; 407(17):4973-93. PubMed ID: 25855150 [TBL] [Abstract][Full Text] [Related]
10. Lipidomics and Biomarker Discovery in Kidney Disease. Afshinnia F; Rajendiran TM; Wernisch S; Soni T; Jadoon A; Karnovsky A; Michailidis G; Pennathur S Semin Nephrol; 2018 Mar; 38(2):127-141. PubMed ID: 29602396 [TBL] [Abstract][Full Text] [Related]
11. Lipidomics: Techniques, Applications, and Outcomes Related to Biomedical Sciences. Yang K; Han X Trends Biochem Sci; 2016 Nov; 41(11):954-969. PubMed ID: 27663237 [TBL] [Abstract][Full Text] [Related]
12. Recent advances in using mass spectrometry for mitochondrial metabolomics and lipidomics - A review. Liu X; Xu G Anal Chim Acta; 2018 Dec; 1037():3-12. PubMed ID: 30292306 [TBL] [Abstract][Full Text] [Related]
13. Applications of mass spectrometry-based targeted and non-targeted lipidomics. Lee HC; Yokomizo T Biochem Biophys Res Commun; 2018 Oct; 504(3):576-581. PubMed ID: 29534960 [TBL] [Abstract][Full Text] [Related]
14. Global Monitoring of the Mammalian Lipidome by Quantitative Shotgun Lipidomics. Nielsen IØ; Maeda K; Bilgin M Methods Mol Biol; 2017; 1609():123-139. PubMed ID: 28660579 [TBL] [Abstract][Full Text] [Related]
15. Recent advances of chromatography and mass spectrometry in lipidomics. Li M; Zhou Z; Nie H; Bai Y; Liu H Anal Bioanal Chem; 2011 Jan; 399(1):243-9. PubMed ID: 21052649 [TBL] [Abstract][Full Text] [Related]
16. Recent advances in lipidomics for disease research. Yang L; Li M; Shan Y; Shen S; Bai Y; Liu H J Sep Sci; 2016 Jan; 39(1):38-50. PubMed ID: 26394722 [TBL] [Abstract][Full Text] [Related]
17. Lipidomics in the study of lipid metabolism: Current perspectives in the omic sciences. Rolim AE; Henrique-Araújo R; Ferraz EG; de Araújo Alves Dultra FK; Fernandez LG Gene; 2015 Jan; 554(2):131-9. PubMed ID: 25445283 [TBL] [Abstract][Full Text] [Related]
18. Clinical advances in analytical profiling of signature lipids: implications for severe non-communicable and neurodegenerative diseases. Sarkar S; Roy D; Chatterjee B; Ghosh R Metabolomics; 2024 Mar; 20(2):37. PubMed ID: 38459207 [TBL] [Abstract][Full Text] [Related]